| abstract |
Crystalline forms of 5-(4-cyclopropyl-lH-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3 yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state: Also provided are processes of manufacture and methods of using the crystalline forms. N " N N N , N C H m pN Compound I |